top of page
Search

Pediatric DTG FAQs for Caregivers and Communities (English, French, Swahili)

  • hivtoolkit
  • Apr 4, 2022
  • 1 min read

This document provides in-depth information on pDTG and answers to frequently asked questions for caregivers and communities to better understand what this product is, why it is an optimal treatment, dosing, how to administer pDTG.


Comments

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • YouTube
Clinton Health Access Initiative

383 Dorchester Avenue, Suite 400

Boston, MA 02127

The goal of the HIV New Product Introduction Toolkit is to stimulate conversations between government, partners, and communities on new product introduction. Please feel free to share any thoughts, questions, or additional resources for consideration by contacting us via email at HIVToolkit@clintonhealthaccess.org.

 

© 2022  Clinton Health Access Initiative - Global HIV Access Program

bottom of page